본문 바로가기
KERD
논문KCI 등재

Epidemiology and risk factors associated with avascular necrosis in patients with autoimmune diseases: a nationwide study

0

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류내과학

초록

Background/Aims: Avascular necrosis (AVN) is a clinical condition characterized by the death of bone components due to interruption in the blood supply. This study aimed to investigate the epidemiology and determine the risk factors for AVN in patients with autoimmune diseases. Methods: We conducted a population-based retrospective cohort analysis using claims data from the Taiwan National Health Insurance Research Database. A total of 49,636 patients with autoimmune diseases between January 1, 2005 and December 31, 2013 were included. Cox regression analysis was used to identify associated risk factors for the development of AVN. Results: A total of 490/49,636 patients (1.0%) developed symptomatic AVN. The systemic lupus erythematosus patients had a higher risk of AVN compared to other autoimmune diseases. AVN was positively correlated with male sex (p < 0.001), alcoholism (p < 0.001), mean daily prednisolone dosage 7.51 to 30 mg (p < 0.001) and > 30 mg (p < 0.001), and total cumulative prednisolone dose 0 g to 5 g (p = 0.002). However, AVN was inversely correlated with cumulative duration of hydroxychloroquine exposure > 0.6 years (p < 0.001). Conclusions: Male sex, systemic lupus erythematosus, alcoholism, mean daily corticosteroid > 7.5 mg and a total cumulative dose of corticosteroid 0 to 5 g were independently associated with the development of AVN in autoimmune patients. While hydroxychloroquine use > 0.6 years conferred significant protection against the development of AVN. Clinicians should regularly assess patients with risk factors to enable the early diagnosis of AVN.

Abstract

Background/Aims: Avascular necrosis (AVN) is a clinical condition characterized by the death of bone components due to interruption in the blood supply. This study aimed to investigate the epidemiology and determine the risk factors for AVN in patients with autoimmune diseases. Methods: We conducted a population-based retrospective cohort analysis using claims data from the Taiwan National Health Insurance Research Database. A total of 49,636 patients with autoimmune diseases between January 1, 2005 and December 31, 2013 were included. Cox regression analysis was used to identify associated risk factors for the development of AVN. Results: A total of 490/49,636 patients (1.0%) developed symptomatic AVN. The systemic lupus erythematosus patients had a higher risk of AVN compared to other autoimmune diseases. AVN was positively correlated with male sex (p < 0.001), alcoholism (p < 0.001), mean daily prednisolone dosage 7.51 to 30 mg (p < 0.001) and > 30 mg (p < 0.001), and total cumulative prednisolone dose 0 g to 5 g (p = 0.002). However, AVN was inversely correlated with cumulative duration of hydroxychloroquine exposure > 0.6 years (p < 0.001). Conclusions: Male sex, systemic lupus erythematosus, alcoholism, mean daily corticosteroid > 7.5 mg and a total cumulative dose of corticosteroid 0 to 5 g were independently associated with the development of AVN in autoimmune patients. While hydroxychloroquine use > 0.6 years conferred significant protection against the development of AVN. Clinicians should regularly assess patients with risk factors to enable the early diagnosis of AVN.

참고문헌 (48)

  1. Sen RK, "Management of avascular necrosis of femoral head at pre-collapse stage", Indian J Orthop, 43, pp.6~16 (2009)
  2. Moya-Angeler J, "Current concepts on osteonecrosis of the femoral head", World J Orthop, 6, pp.590~601 (2015)
  3. Kaushik AP, "Osteonecrosis of the femoral head : an update in year 2012", World J Orthop, 3, pp.49~57 (2012)
  4. Drescher W, "Steroid-related osteonecrosis : an update", Nephrol Dial Transplant, 26, pp.2728~2731 (2011)
  5. Fukushima W, "Nationwide epidemiologic survey of idiopathic osteonecrosis of the femoral head", Clin Orthop Relat Res, 468, pp.2715~2724 (2010)
  6. Klippel JH, "Avascular necrosis in systemic lupus erythematosus : silent symmetric osteonecroses", Am J Med, 67, pp.83~87 (1979)
  7. Sayarlioglu M, "Risk factors for avascular bone necrosis in patients with systemic lupus erythematosus", Rheumatol Int, 32, pp.177~182 (2012)
  8. Hurley RM, "Avascular necrosis of the femoral head in childhood systemic lupus erythematosus", Can Med Assoc J, 111, pp.781~784 (1974)
  9. Bergstein JM, "Avascular necrosis of bone in systemic lupus erythematosus", J Pediatr, 85, pp.31~35 (1974)
  10. Dooley MA, "Environmental epidemiology and risk factors for autoimmune disease", Curr Opin Rheumatol, 15, pp.99~103 (2003)
  11. Gleicher N, "Gender as risk factor for autoimmune diseases", J Autoimmun, 28, pp.1~6 (2007)
  12. Nussinovitch U, "The role of gender and organ specific autoimmunity", Autoimmun Rev, 11, pp.A377~A385 (2012)
  13. Mok MY, "Risk factors for avascular necrosis of bone in patients with systemic lupus erythematosus : is there a role for antiphospholipid antibodies?", Ann Rheum Dis, 59, pp.462~467 (2000)
  14. Oinuma K, "Osteonecrosis in patients with systemic lupus erythematosus develops very early after starting high dose corticosteroid treatment", Ann Rheum Dis, 60, pp.1145~1148 (2001)
  15. Assouline-Dayan Y, "Pathogenesis and natural history of osteonecrosis", Semin Arthritis Rheum, 32, pp.94~124 (2002)
  16. Rascu A, "Osteonecrosis in systemic lupus erythematosus, steroid-induced or a lupus-dependent manifestation?", Lupus, 5, pp.323~327 (1996)
  17. Shigemura T, "Incidence of osteonecrosis associated with corticosteroid therapy among different underlying diseases: prospective MRI study", Rheumatology(Oxford), 50, pp.2023~2028 (2011)
  18. Zizic TM, "Corticosteroid therapy associated with ischemic necrosis of bone in systemic lupus erythematosus", Am J Med, 79, pp.596~604 (1985)
  19. Nagasawa K, "Very early development of steroid-associated osteonecrosis of femoral head in systemic lupus erythematosus : prospective study by MRI", Lupus, 14, pp.385~390 (2005)
  20. Aranow C, "Clinically occult avascular necrosis of the hip in systemic lupus erythematosus", J Rheumatol, 24, pp.2318~2322 (1997)
  21. Balighi K, "Temporal course of avascular femoral head necrosis in patients with pemphigus vulgaris", J Dtsch Dermatol Ges, 14, pp.1016~1021 (2016)
  22. Dubois EL, "Avascular(aseptic)bone necrosis associated with systemic lupus erythematosus", JAMA, 174, pp.966~971 (1960)
  23. Zonana-Nacach A, "Damage in systemic lupus erythematosus and its association with corticosteroids", Arthritis Rheum, 43, pp.1801~1808 (2000)
  24. Massardo L, "High-dose intravenous methylprednisolone therapy associated with osteonecrosis in patients with systemic lupus erythematosus", Lupus, 1, pp.401~405 (1992)
  25. Mok CC, "Risk factors for avascular bone necrosis in systemic lupus erythematosus", Br J Rheumatol, 37, pp.895~900 (1998)
  26. Seamon J, "The pathogenesis of nontraumatic osteonecrosis", Arthritis, 2012, pp.601763~ (2012)
  27. Weinstein RS, "Glucocorticoid-induced osteoporosis and osteonecrosis", Endocrinol Metab Clin North Am, 41, pp.595~611 (2012)
  28. Wang GJ, "Fat-cell changes as a mechanism of avascular necrosis of the femoral head in cortisone-treated rabbits", J Bone Joint Surg Am, 59, pp.729~735 (1977)
  29. Cui Q, "Steroid-induced adipogenesis in a pluripotential cell line from bone marrow", J Bone Joint Surg Am, 79, pp.1054~1063 (1997)
  30. Drescher W, "Endothelin-1-induced femoral head epiphyseal artery constriction is enhanced by long-term corticosteroid treatment", J Bone Joint Surg Am, 88(Suppl 3), pp.173~179 (2006)
  31. Kerachian MA, "Glucocorticoids in osteonecrosis of the femoral head : a new understanding of the mechanisms of action", J Steroid Biochem Mol Biol, 114, pp.121~128 (2009)
  32. Leventhal GH, "Aseptic necrosis of bone in systemic lupus erythematosus", Semin Arthritis Rheum, 4, pp.73~93 (1974)
  33. Kunyakham W, "Prevalence and risk factor for symptomatic avascular necrosis development in Thai systemic lupus erythematosus patients", Asian Pac J Allergy Immunol, 30, pp.152~157 (2012)
  34. Zhu KK, "The risk factors of avascular necrosis in patients with systemic lupus erythematosus : a meta-analysis", Inflammation, 37, pp.1852~1864 (2014)
  35. Gladman DD, "Predictive factors for symptomatic osteonecrosis in patients with systemic lupus erythematosus", J Rheumatol, 28, pp.761~765 (2001)
  36. Asherson RA, "Avascular necrosis of bone and antiphospholipid antibodies in systemic lupus erythematosus", J Rheumatol, 20, pp.284~288 (1993)
  37. Calvo-Alen J, "Systemic lupus erythematosus in a multiethnic US cohort(LUMINA) : XXIV. Cytotoxic treatment is an additional risk factor for the development of symptomatic osteonecrosis in lupus patients : results of a nested matched case-control study", Ann Rheum Dis, 65, pp.785~790 (2006)
  38. Migkos MP, "Effect of hydroxychloroquine on the lipid profile of patients with Sjogren syndrome", J Rheumatol, 41, pp.902~908 (2014)
  39. Belizna C, "Hydroxychloroquine as an anti-thrombotic in antiphospholipid syndrome", Autoimmun Rev, 14, pp.358~362 (2015)
  40. Al Saleh J, "Predictors of avascular necrosis of the hip in Emiratis patients with systemic lupus erythematosus", Egypt J Immunol, 17, pp.29~40 (2010)
  41. Joo YB, "Prevalence, incidence, and associated factors of avascular necrosis in Korean patients with systemic lupus erythematosus : a nationwide epidemiologic study", Rheumatol Int, 35, pp.879~886 (2015)
  42. Moskal JT, "Hypercholesterolemia: an association with osteonecrosis of the femoral head", Am J Orthop(Belle Mead NJ), 26, pp.609~612 (1997)
  43. Pritchett JW, "Statin therapy decreases the risk of osteonecrosis in patients receiving steroids", Clin Orthop Relat Res, (386), pp.173~178 (2001)
  44. Nevskaya T, "A meta-analysis of avascular necrosis in systemic lupus erythematosus : prevalence and risk factors", Clin Exp Rheumatol, 35, pp.700~710 (2017)
  45. Gurion R, "Avascular necrosis in pediatric systemic lupus erythematosus : a brief report and review of the literature", Pediatr Rheumatol Online J, 13, pp.13~ (2015)
  46. Prasad R, "The role of non-corticosteroid related factors in osteonecrosis(ON)in systemic lupus erythematosus : a nested case-control study of inception patients", Lupus, 16, pp.157~162 (2007)
  47. Uea-areewongsa P, "Factors associated with osteonecrosis in Thai lupus patients : a case control study", J Clin Rheumatol, 15, pp.345~349 (2009)
  48. Fialho SC, "Disease activity as a major risk factor for osteonecrosis in early systemic lupus erythematosus", Lupus, 16, pp.239~244 (2007)

관련 논문AI추천

이 간행물의 다른 논문 (20건)